About Aerocrine
Aerocrine is a company based in Solna (Sweden) founded in 1997. Aerocrine has completed 1 acquisition, including Apieron. Aerocrine operates in a competitive market with competitors including Circassia Pharmaceuticals and SpiroFriend, among others.
- Headquarter Solna, Sweden
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$363.41 K (USD), Grant
Jan 01, 2015
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Aerocrine
Investors in Aerocrine
Aerocrine has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Aerocrine
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aerocrine
Aerocrine has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Apieron.
Investment portfolio details for Aerocrine
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Functions as an asthma monitoring device for health management.
|
Locked | Locked | 2001 | Locked |
Complete acquisition details for Aerocrine
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Aerocrine
Detailed financials for Aerocrine
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aerocrine Comparisons
Peer comparison for Aerocrine
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aerocrine
Aerocrine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Circassia Pharmaceuticals and SpiroFriend, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Treatments for asthma, COPD, and allergies are developed by Circassia.
|
|
| Locked | Locked | Locked |
Develops portable devices for measuring lung function and exhaled gases in patients.
|
Detailed competitors of Aerocrine
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aerocrine
Complete news archive for Aerocrine
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aerocrine
Aerocrine was founded in 1997 and raised its 1st funding round 18 years after it was founded.
Aerocrine is headquartered in Solna, Sweden.
Aerocrine was founded in 1997 in Solna, Sweden, focusing on medical devices within the respiratory health sector. Devices such as NIOX VERO are produced to measure nitric oxide levels in exhaled air, aiding assessment of airway inflammation in conditions like asthma. This technology evolved from NIOX MINO, with NIOX VERO introduced in 2014. Acquisition by Circassia occurred in May 2015 for 219 million.
Aerocrine's top competitors include Circassia Pharmaceuticals and SpiroFriend.
Aerocrine has made 1 acquisition, including Apieron.
Aerocrine has 1 investor. Key investors include European Union.